Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin.

Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin. Abstract Text:

    yusuke komiYusuke Komi,osamu ohnoOsamu Ohno,yasuhiro suzukiYasuhiro Suzuki,mariko shimamuraMariko Shimamura,kentaro shimokadoKentaro Shimokado,kazuo umezawaKazuo Umezawa,soichi kojimaSoichi Kojima,yusuke komiYusuke Komi,osamu ohnoOsamu Ohno,yasuhiro suzukiYasuhiro Suzuki,mariko shimamuraMariko Shimamura,kentaro shimokadoKentaro Shimokado,kazuo umezawaKazuo Umezawa,soichi kojimaSoichi Kojima,yusuke komiYusuke Komi,osamu ohnoOsamu Ohno,yasuhiro suzukiYasuhiro Suzuki,mariko shimamuraMariko Shimamura,kentaro shimokadoKentaro Shimokado,kazuo umezawaKazuo Umezawa,soichi kojimaSoichi Kojima,

    BACKGROUND: Sangivamycin, an antibiotic with anti-tumor and anti-herpes virus activities by inhibiting both DNA/RNA synthesis and protein kinase C activity, was reported to suppress selectively DNA synthesis and growth of human umbilical vein endothelial cells and their tube formation in vitro. Here, to address the potential clinical use of sangivamycin in future, we investigated its anti-angiogenic effect in in vivo chicken chorioallantoic membrane (CAM) and mouse dorsal air sac (DAS) assays, and investigated underlying mechanism. METHODS: The effect of sangivamycin on blood vessel formation in CAM was observed under the microscope after treating for two days. For DAS assays, chambers fulfilled with tumor cells were implanted beneath mouse dorsal skin. After the mice were administered with sangivamycin, tumor-induced angiogenesis was observed under the microscope. The effect of sangivamycin on ATP synthesis on the endothelial cell surface was assayed by measuring ATP production with bioluminescence assay. RESULTS: Sangivamycin suppressed angiogenesis within CAM down to 94-71%, which was partially blocked by simultaneous addition of a 40-fold excess of adenosine. Sangivamycin also inhibited tumor-angiogenesis in the DAS assay by 61%, and suppressed ATP production on the endothelial cell surface by 75%. CONCLUSION: Sangivamycin inhibits the in vivo angiogenesis within CAM and tumor-induced angiogenesis within mouse dorsal skin, at least in part via inhibiting endothelial cell surface ATP metabolism in addition to inhibition of DNA/RNA synthesis and/or protein kinase C activity, suggesting a potential clinical use of sangivamycin as a novel anti-cancer reagent capable of targeting not only cancer cells but also endothelial cells.

    Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin. Publishing Authors By Initials

    y komiY Komi,o ohnoO Ohno,y suzukiY Suzuki,m shimamuraM Shimamura,k shimokadoK Shimokado,k umezawaK Umezawa,s kojimaS Kojima,y komiY Komi,o ohnoO Ohno,y suzukiY Suzuki,m shimamuraM Shimamura,k shimokadoK Shimokado,k umezawaK Umezawa,s kojimaS Kojima,y komiY Komi,o ohnoO Ohno,y suzukiY Suzuki,m shimamuraM Shimamura,k shimokadoK Shimokado,k umezawaK Umezawa,s kojimaS Kojima,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Japanese journal of clinical oncology

    VOLUME: 37

    Page Numbers: 867-73

    Journal Abbreviation: Jpn. J. Clin. Oncol.

    ISSN: 1465-3621

    DAY: 23

    MONTH: 10

    YEAR: 2007

    Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 313225

    Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin.

    AFFILIATION: Molecular Cellular Pathology Research Unit, RIKEN, Wako, Saitama 351-0198, Japan. skojima@postman.riken.go.jp

    Country: Japan

    Japan Research PublicationJapan Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Jpn J Clin Oncol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News